Five or more dopine receptor genes are expressd in brain. However, the phacological similarities of the encoded DI-Ds receptors have hindered studies of the localizion and functions of the subtypes. To better understand the roles of the individual receptors, antibodies were raised apinst recombinant D1 and D2 proteins and were shown to bind to the receptor subtpes spefically in Western blot and immunoprecipitation studies. Each antibody reacted selectively with the r ive receptor protein expressed both in cells transfected with the cDNAs and in brain. By immunocytochemistry, D1 and D2 had similr reonal distibutions in rat, monkey, and human brain, with the most intense saning in sriatum, olfactory bulb, and substantia nigra. Within each region, however, the precise distributions ofeach subtype were dstinct and often complementary. Di and D2 were differentidy enriched in striatal patch and matrix compwrtments, in selective layers of the olfactory bulb, and in either substantia nigra pars compacta or reticulata. Electron microscopy demonstrated that D1 and D2 also had highly selective subcellular distributions. In the rat nestiatum, the majority of D1 and D2 immunoreactivity was localized in postsynaptic sites in subsets of spiny dendrites and spine heads in rat nosriatum. Presynaptic D1 and D2 receptors were also observed, indicating both ubtypes may regulate neurotransmitter rebase. DI was also present in axon terminals in the substantia nigra. These results provide a morphologkal substrate for understanding the preand postsynaptic functions of the genetically defined DI and D2 receptors in discrete neuronal circuits in mammalin brain.
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A family of at least five dopamine receptor genes, D1-D5, has been identified in both rodents and humans (1, 2) . The encoded receptors can be classified as members of either the D1 (D1, DOB, and D5) or D2 (D2, D3, and D4) subfamily based on sequence homologies and pharmacology. The subtype mRNAs have all been detected in rodent brain (3) (4) (5) (6) (7) (8) (9) , although there is little information about the distribution and levels ofthe encoded receptor proteins (10, 11) . Protein levels and distribution may not match the mRNAs (3, 6 (13) encoding the C-terminal 97 aa] and D2i3 [nt 661-1020 (14) encoding 120 aa of the i3 loop from the D2s splice variant] were subcloned into pGEX-2T, expressed as soluble fusion proteins in bacteria, and affinity-purified as described (12, 15) . The recombinant plasmids were confirmed by sequence analysis and encode a 27.5-kDa polypeptide fragment of glutathione S-transferase (GST) fused to the receptor polypeptide (Dic-GST and D%-GST). High yields (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) Antibodies were affinity-purified on the respective purified fusion proteins conjugated to Affi-Gel (Bio-Rad) as described (12) . Sera were preadsorbed with GST and bacterial lysates prior to affinity purification to remove antibodies reactive with the nondopamine receptor portion ofthe fusion proteins. The two antisera for each receptor yielded similar results.
Immunoblot Analysis. SDS/PAGE was used to fractionate total protein from bacterial cultures expressing dopamine receptor fusion proteins, membrane protein from mammalian cells transfected with full-length D1 (Y1-HD1) and )2 (A9L-HD2L) cDNAs, or dissected regions of rat and canine brain. Gels were electroblotted onto Immobilon-P, and blots were incubated with affinity-purified antibodies (0.5-1.0 Mg/ml) or antisera (1:250 dilution) and visualized using enhanced chemiluminescence (Amersham) as described (16 1% digitonin as described (17) . Solubilized D1 and D2 receptors (0.2-0.4 pmol) were incubated with various concentrations of preimmune sera or antisera for 12 hr at 4°C followed Immunocytochemnstry. Brains were obtained from 20 male albino rats (Charles River Breeding Laboratories, 250-350 g), two male Macaca mulatta (rhesus) monkeys, and two humans (7.5-and 12-hr postmortem intervals). Animals were fixed by perfusion with 3-4% (wt/vol) paraformaldehyde (pH 7.6) and then with buffered 10%o (wt/vol) sucrose (12); blocks (0.5-1.0 cm) of human brain were placed in the same fixative for 24-36 hr and equilibrated in sucrose prior to sectioning. Tissue sections were processed for immunocytochemistry as described (12) . For electron microscopy, glutaraldehyde (0.1-0.5%) was added to the fixative, tissue was sectioned with a Vibratome, and detergent was omitted from antibody solutions. This tissue was further processed with 0.1% osmium tetroxide, block-stained in uranyl acetate, embedded with Durcupan resin (Fluka), sectioned with an ultramicrotome, and analyzed on a Zeiss EM10 electron microscope. Affinity-purified antibodies to D1 and D2 were used at 0.5-1.0 u&g/ml. Monoclonal antibody to tyrosine hydroxylase (Boehringer Mannheim) was used at 0.2 ,ug/ml. Controls consisted of adsorption of the receptor antibodies with GST, Dic-GST, and D2-GST (each at 100 ug/ml). An additional series of sections were incubated in normal rabbit immunoglobulin (1.0 jug/ml).
RESULTS
Specificity of Antibodies to D1 and D2 Receptors. In Western blot experiments, affinity-purified antibodies to Di and D2 receptors reacted strongly with Dl,-GST and D2)-GST, respectively, with no cross-reactivity to bacterial proteins, GST, or the other dopamine receptor fusion protein. The antibodies also did not cross-react with the fusion proteins derived from the same regions of D3, D4, and Ds receptors (data not shown). The D1 and D2 antibodies also bound to the respective cloned and native brain receptors specifically (Fig.  1 ). On blots of mammalian cells transfected with full-length cDNAs, prominent Di-immunoreactive bands corresponded in size to that predicted from sequence analysis and biochemical studies of the glycosylated and deglycosylated receptors (18) . D1 antibodies showed no cross-reactivity with D2 receptor in transfected cells. On blots of brain, Di immunoreactivity was the same size as the cloned Di receptor and showed marked enrichment in striatum compared to frontal cortex and hippocampus. D2 antibodies were reactive specifically with the cloned D2 receptor in transfected A9L cells, including a protein doublet at -40 kDa, corresponding to the predicted size of D2 (14) and a broad band of immunoreactivity at 65-97 kDa, similar to the size of mature photoaffinity-labeled receptors (19 (preimmune IgG) (Fig. 1 C and D) . Each antisera was able to precipitate 80-100% of the respective receptors at dilutions to 1:500 and 1:1000. Similar results were obtained from transfected cells expressing D1 or D2 receptors (data not shown). At dilutions of 1:250 for anti-D1 antibodies, virtually all D1 receptor activity was immunoprecipitated, unlike that seen in native membranes. Preimmune sera and the heterologous antisera showed little or no effect on binding activity in transfected cells or brain.
Di and D2 Receptor Localization in Brain. D1 and D2 were localized in rat, monkey, and human brain by immunocytochemistry. Specificity of localization was confirmed by control experiments in which the antibodies were preadsorbed with purified GST (the gene product fused at the N terminus of each receptor polypeptide) or the dopamine receptor fusion proteins. Staining with both antibodies was abolished by preadsorption on the homologous fusion protein, but not after preadsorption on GST alone or the heterologous fusion protein (data not shown).
The distributions of Di and D2 were strikingly similar to that of tyrosine hydroxylase, a marker of dopaminergic neuronls, with dense immunoreactivity in striatum, substantia nigra, and olfactory bulb in rat brain (Fig. 2) . However, the cellular and subcellular distributions of D1 and D2 were distinct. Both receptors were concentrated in the striatum, although the relative levels and mosaic distributions of each subtype in caudate-putamen, nucleus accumbens, and olfactory tubercle were unique ( Fig. 3 A and B relatively low levels ofimmunoreactivity in perikarya. DI and D2 were also both localized in the substantia nigra; Di was enriched in the neuropil ofthe substantia nigra pars reticulata (SNr) and D2 was enriched in perikarya and dendrites in the pars compacta (Fig. 3 CandD) . Di was more dense in the SNr and entopeduncular nucleus than in the external segment of globus pallidus. In contrast, D2 was more dense in the external segment of globus pallidus than in other striatal projection sites. In olfactory bulb, Di was present in the internal granular and plexiform layers, whereas D2 was concentrated in the olfactory nerve and glomerular and external plexiform layers. Cortical areas and hippocampus had relatively low levels of DI and D2 immunoreactivity, although neurons expressing either subtype were detected in limbic regions (e.g., piriform, entorhinal, subiculum, and retrosplenial cortex). In the amygdala, Di was in the intercalated and basolateral nuclei, and D2 was in the central nucleus. Diencephalon and most hindbrain regions displayed little or no immunoreactivity, except for Di in the cerebellar granule cell layer and in motor neurons and D2 in the mammillary body, superficial layers of the superior colliculus, and the dorsal horn of the spinal cord.
Di and D2 receptors were also localized in the monkey (data not shown) and human (Fig. 4) (areas low in calbindin) in the caudate; D2 immunoreactivity was more evenly distributed in both striatal compartments. DI was present in the internal segment of globus pallidus and SNr, whereas low levels of D2 were present in the external segment of globus pallidus.
Electron microscopy was used to determine the subcellular localization of DI and D2 immunoreactivity in the rat basal ganglia (Fig. 5 ). DI and D2 were both localized predominantly in spiny dendrites and spine heads within the neuropil of the striatum; less immunoreactivity was visible in somata. Only a subset of these spiny dendrites and neurons displayed immunoreactivity for either receptor. Axon terminals were infrequent but well-labeled with each antibody. The reaction product was distributed throughout the cytoplasm of these processes. However, more dense punctate concentrations of reaction product were associated with the inner face of the plasma membranes of dendrites and spines. Postsynaptic densities at asymmetrical synapses in labeled spine heads were often intensely labeled. Axon terminals immunoreactive for DI and D2 receptor proteins formed symmetrical Fio. 5. Electron micrographs of D1 (A, C, and D) and D2 (B, E, and F) immunoreactivity in rat. In rat neostriatum, the majority of immunoreactivity for both D1 and D2 (A and B, respectively) is localized in spiny dendrites (d) and spine heads (s). Note the discontinuous distribution of Di along the inner surface of the membrane (arrows). Di (C) and D2 (E) immunoreactive spine heads receiving asymmetric synaptic contacts from unlabeled axons (a); both receptors appear to be enriched in postsynaptic densities (arrows). In the SNr (D), Di immunoreactivity is present in preterminal axons (arrow) and inaxon terminals (a) in synaptic contact with dendrites (d). In striatum, both receptors are also presynaptic; F shows an example of a D2 immunoreactive axon terminal (a) in synaptic contact with an unlabeled dendrite (d).
synapses exclusively, and primarily with unlabeled dendritic shafts. In SNr, D1 immunoreactivity was localized in axon terminals forming symmetrical synapses.
DISCUSSION
In the present study, we developed anti-fusion protein antibodies for immunocytochemical localization of D1 and D2 proteins in rat, monkey, and human brain. The specificity of the antibodies was established by several independent criteria: of striatal Di and D2 receptors are located postsynaptically on spiny dendrites and spine heads, undoubtedly derived from medium-sized GABAergic projection neurons (where GABA is -tyaminobutyric acid). The scarcity of immunoreactivity elsewhere in these neurons indicates that the receptor proteins are transported within cells in a highly selective manner. The receptors were often concentrated at discrete submembranous sites along dendritic shafts, spines, and at postsynaptic densities. It is interesting that many of the labeled postsynaptic densities were at asymmetrical axospinous synapses that are usually received from corticostriatal and thalamostriatal afferents (28, 29) that utilize excitatory amino acids as neurotransmitters (24) . Dopaminergic synapses are established to be in close proximity on spine necks (30) .
Thus, extrasynaptic dopamine may stimulate DI and D2 receptors to directly modulate cortical and/or thalamic inputs to medium spiny neurons. Further, the compartmentalization of DI and D2 raises the possibility that excitatory afferents from distinct cortical areas and thalamic nuclei are modulated by different subtypes.
Heterogeneous presynaptic dopamine receptors regulate the release of dopamine, -aminobutyric acid, acetylcholine, and excitatory amino acids in striatum (31) . Our electron microscopic findings of DI and D2 receptor proteins in axon terminals forming symmetric synapses on dendritic shafts provide morphological evidence that both molecular subtypes are presynaptic. Symmetrical synapses in striatum arise from local axon collaterals and substantia nigra (29) .
Since nigral inputs are principally localized on spine necks, the presynaptic D1 and D2 receptors observed in the present study are likely to be on local axon collaterals of the GABAergic projection neurons. Pharmacologic studies have indicated presynaptic D2 modulation of corticostriatal (32) and nigrostriatal (33) 
